Motor Neuron Disease

Toxic proteins damage nerve cells

Scientists at the Max Planck Institute for Biology of Ageing in Cologne and University College London have now unearthed the way in which a specific genetic mutation leads to neuronal damage in two serious ...

Aug 12, 2014
popularity 5 / 5 (6) | comments 0

Patients' stories used to improve care on wards

A research project led by Oxford University is showing how patient experiences can be used to improve healthcare – not through targets and surveys, but by getting doctors, nurses and patients talking together about care ...

Mar 05, 2014
popularity not rated yet | comments 0

The motor neurone diseases (or motor neuron diseases) (MND) are a group of neurological disorders that selectively affect motor neurones, the cells that control voluntary muscle activity including speaking, walking, breathing, swallowing and general movement of the body. They are generally progressive in nature, and can cause progressive disability and death. The drug riluzole can slow progression slightly; apart from this the medical care is supportive. The condition was first described in full by the French neurologist Jean-Martin Charcot in 1869.

This text uses material from Wikipedia licensed under CC BY-SA

Latest Spotlight News

Screening for diabetes at dental visits using oral blood

It is estimated that 8.1 million of the 29.1 million Americans living with diabetes are undiagnosed and many who have diabetes have poor glycemic control. Given that each year many Americans visit a dental provider but not ...

Thinking of God makes people bigger risk-takers

Reminders of God can make people more likely to seek out and take risks, according to research published in Psychological Science, a journal of the Association for Psychological Science. The findings sugges ...

Marshaling the body's own weapons against psoriasis

A three-character code brings relief to patients with psoriasis and sheds light on complex immunoregulation processes: IL-4, an abbreviation for the endogenous signaling molecule Interleukin 4. The substance's ...

Watching the death throes of tumours

A clinical trial due to begin later this year will see scientists observing close up, in real time – and in patients – how tumours respond to new drugs.